-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QEtQEq0T1sLga2F4Oy34MW41cINFFQh5sBhx1AK9xZk9E8phyKWopcemGmywBLmh
 wQobvSJ1CzOUaOSpeduWbA==

<SEC-DOCUMENT>0001019687-09-000870.txt : 20090501
<SEC-HEADER>0001019687-09-000870.hdr.sgml : 20090501
<ACCEPTANCE-DATETIME>20090316203955
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001019687-09-000870
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20090316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>


March 17, 2009


U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:Martin James, Senior Assistant Chief Accountant
and/or Kate Tillan, Assistant Chief Accountant

Re:     Biomerica, Inc.
        Form 10-KSB for the Fiscal Year Ended May 31, 2008
        Filed August 29, 2008
        Form 10-Q for the Quarterly Period Ended November 30, 2008
        File No. 000-08765


Dear Mr. James and Ms. Tillan:

The following are our responses to your letter dated March 4, 2009, numbered in
the order of your letter.

    1.   Form 10-Q for the Quarterly Period Ended November 30, 2008

         Item 4. Controls and Procedures, page 13

SEC COMMENTS:

    1.   Please refer to prior comment 3. We note from the proposed revisions to
         your disclosure in your response that the wording is still not
         consistent with the language that appears in the definition of
         "disclosure controls and procedures" set forth in Rule 13a-15(e) of the
         Exchange Act. For example, we note that you use the word "declared" in
         place of "disclosed". Please either remove the language in your future
         filings or revise the disclosure so that the language that appears
         after the word "effective" is substantially similar in all material
         respects to the language that appears in the entire two-sentence
         definition of "disclosure controls and procedures" set forth in Rule
         13a-15(e).

    2.   Further we note from your response that you intend to add disclosure in
         future filings stating, in part, that "any controls and procedures, no
         matter how well designed and operated, can provide only reasonable
         assurance of achieving their objectives". Please revise future filings
         to state clearly, if true, that your disclosure controls and procedures
         are DESIGNED TO provide reasonable assurance of achieving their
         objectives and that your disclosure controls and procedures are
         effective at that reasonable assurance level. In the alternative,
         remove the reference to the level of assurance of your disclosure
         controls and procedures. Please refer to Section II.F.4 of Management's
         Reports on Internal Control Over Financial Reporting and Certification
         of Disclosure in Exchange Act Periodic Reports, SEC Release No.
         33-8238, available on our website at
         http://www.sec.gov/rules/final/33-8238.htm.
         -------------------------------------------
<PAGE>

RESPONSE: In response to both comments above, in future filings the Company will
modify its Item 4. Controls and Procedures paragraph to read as follows:

         4. CONTROLS AND PROCEDURES.

         DISCLOSURE CONTROLS AND PROCEDURES

     Our management evaluated the effectiveness of our disclosure controls and
procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended, or the Exchange Act, as of the end of the
period covered by this report. Our management recognizes that any controls and
procedures, no matter how well designed and operated, can provide only
reasonable assurance of achieving their objectives and management is required to
apply its judgment in evaluating the cost-benefit relationship of possible
controls and procedures. The disclosure controls and procedures have been
designed to provide reasonable assurance of achieving their objectives and the
Chief Executive Officer and Chief Financial Officer have concluded that our
disclosure controls and procedures are effective at the "reasonable assurance"
level. Based upon that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that the disclosure controls and procedures were
effective to ensure that information required to be disclosed in the reports
that we file and submit under the Exchange Act is (1) recorded, processed,
summarized and reported within the time periods specified in the Commission's
rules and forms; and (2) accumulated and communicated to the Company's
management, including its Chief Executive Officer and Chief Financial Officer,
as appropriate, to allow timely decisions regarding required disclosure.

     There have been no changes in our internal control over financial reporting
identified in connection with the evaluation that occurred during our last
fiscal quarter that has materially affected, or that is reasonably likely to
materially affect, our internal control over financial reporting.

     Please let us know if you need anything else from us at this time in order
to respond to this letter and, if so, we will respond quickly to your request.

          Sincerely,

          /s/ Janet Moore
          ---------------
          Janet Moore
          Chief Financial Officer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
